LongevityInvestigational

Bioregulator Peptides (Khavinson)

Overview

Bioregulator peptides are a class of short synthetic peptides, typically 2 to 4 amino acids in length, developed by Russian researcher Vladimir Khavinson based on sequences derived from organ-specific tissues. These peptides are theorized to exert tissue-specific regulatory effects by interacting with chromatin to modulate gene expression and restore age-related functional declines. Examples include thymus-derived peptides (Thymalin), pineal peptides (Epithalamin), and vascular peptides. The underlying hypothesis is that peptide bioregulators can reverse or slow aging by re-establishing youthful patterns of protein synthesis in target organs.

Key Research Findings

Studies published primarily in Russian and Eastern European journals report lifespan extension and reduced age-related pathology in animal models treated with Khavinson peptides. Clinical studies, including those on Epithalamin in elderly populations, have suggested benefits on biomarkers of aging and mortality, but these trials are generally small and lack replication in large-scale, Western, peer-reviewed settings. Regulatory approval is limited to Russia and former Soviet states, and international acceptance awaits independent validation and mechanistic clarification.

Route of Administration

Subcutaneous injection, Oral, Intramuscular injection

Regulatory Status

Investigational

Interested in Bioregulator Peptides (Khavinson)?

Find a verified provider experienced with Bioregulator Peptides (Khavinson) protocols in your area. All providers are credentialed and use compliant sourcing.

Find a Bioregulator Peptides (Khavinson) Provider

Related Peptides

Epithalon (Epitalon)

Research Phase

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural epithalamin peptide produced by the pineal gland. Epithalon activates telomerase, the enzyme responsible for maintaining telomere length, thereby potentially extending cellular replicative capacity. It also stimulates melatonin production and modulates neuroendocrine system function associated with aging.

MOTS-c

Research Phase

A mitochondrial-derived peptide encoded by the 12S rRNA gene of mitochondrial DNA. MOTS-c is a 16-amino acid peptide that acts as an exercise mimetic by activating AMPK and regulating metabolic homeostasis. It translocates to the nucleus under metabolic stress to regulate nuclear gene expression related to glucose metabolism and cellular stress responses.

Humanin

Research Phase

A 24-amino acid mitochondrial-derived peptide encoded within the 16S rRNA region of mitochondrial DNA. Humanin exerts cytoprotective and neuroprotective effects by interacting with IGFBP-3, BAX, and the FPRL-1 receptor. It inhibits apoptosis through suppression of the intrinsic mitochondrial death pathway and reduces amyloid-beta-induced neurotoxicity.

NAD+ Precursors (NMN)

In Clinical Trials

Nicotinamide mononucleotide (NMN) is a direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for cellular metabolism, DNA repair (via sirtuins and PARPs), and circadian rhythm regulation. NAD+ levels decline with age, and NMN supplementation restores tissue NAD+ levels, activating SIRT1-mediated pathways that regulate mitochondrial biogenesis and oxidative stress resistance.